Zacks highlights its proprietary ranking system, combining the Zacks Rank with Style Scores (Value, Growth, Momentum, VGM), to identify promising stocks. Integer Holdings Corporation (ITGR), a medical device manufacturer, is presented as a notable long-term value opportunity, despite its Zacks Rank #3 (Hold), due to its strong 'A' VGM Score and 'B' Value Score, supported by a 16.32 forward P/E. Recent upward revisions in FY2025 earnings estimates by analysts, increasing to $6.38 per share, and a positive average earnings surprise of +1.3% further bolster its investment case.
Integer Holdings Corporation (ITGR) presents a case of conflicting signals, positioning it as a value-oriented opportunity despite a neutral rating. According to the Zacks framework, while ITGR holds a #3 (Hold) rank, its underlying metrics are strong, meriting a top-tier 'A' VGM Score and a 'B' Value Score. This value proposition is supported by an attractive forward P/E ratio of 16.32. More significantly, the forward outlook is improving, with five analysts revising fiscal 2025 earnings estimates upward in the last 60 days. This has lifted the Zacks Consensus Estimate by $0.05 to $6.38 per share. The company, a contract manufacturer for the medical device industry, also demonstrates consistent execution with a historical average earnings surprise of +1.3%. The analysis suggests that while the stock may lack immediate-term catalysts implied by a 'Buy' rating, its favorable valuation and positive earnings revision trajectory make it a noteworthy candidate for long-term value investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment